The Impact of Device Modifications and Pressure Delivery on Adherence.
APAP
Bilevel
C-Flex
CPAP
Expiratory pressure relief
Humidification
OSA
Ramp
Journal
Sleep medicine clinics
ISSN: 1556-4088
Titre abrégé: Sleep Med Clin
Pays: United States
ID NLM: 101271531
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
entrez:
24
1
2021
pubmed:
25
1
2021
medline:
22
5
2021
Statut:
ppublish
Résumé
This article reviews the evidence to date examining whether adherence to positive airway pressure (PAP) therapy is affected by any device modifications to pressure delivery. To date there is no robust evidence from systematic reviews and meta-analyses indicating that any modification to standard fixed-pressure PAP makes a clinically significant difference to patient adherence to therapy. The main modifications are reviewed in this article and whether improving pressure could drive adherence, in turn improving patient outcomes, is discussed.
Identifiants
pubmed: 33485533
pii: S1556-407X(20)30103-X
doi: 10.1016/j.jsmc.2020.10.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-84Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure R. Killick has nothing to declare. N.S. Marshall previously has conducted a trial mentioned in this review, funded by Fisher & Paykel (SensAwake device). He has received in-kind support (investigational product supplied free of charge) from Respironics (now Phillips—the C-Flex modification) for another trial discussed in this review. He also has received in-kind support (investigational product) from Teva (formerly Cephalon) and Neurim for trials outside of the scope of this review, except for 1 trial supported by Teva, which is cited in this review in the context of reestablishing patients on PAP after they have abandoned it.